232 related articles for article (PubMed ID: 21687347)
1. Antidepressant potential of nitrogen-containing heterocyclic moieties: An updated review.
Siddiqui N; Andalip ; Bawa S; Ali R; Afzal O; Akhtar MJ; Azad B; Kumar R
J Pharm Bioallied Sci; 2011 Apr; 3(2):194-212. PubMed ID: 21687347
[TBL] [Abstract][Full Text] [Related]
2. Mirtazapine: only for depression?
San L; Arranz B
Acta Neuropsychiatr; 2006 Jun; 18(3-4):130-43. PubMed ID: 26989965
[TBL] [Abstract][Full Text] [Related]
3. Duloxetine in Psychiatric Disorders: Expansions Beyond Major Depression and Generalized Anxiety Disorder.
Muscatello MRA; Zoccali RA; Pandolfo G; Mangano P; Lorusso S; Cedro C; Battaglia F; Spina E; Bruno A
Front Psychiatry; 2019; 10():772. PubMed ID: 31749717
[No Abstract] [Full Text] [Related]
4. [Prevalence of psychiatric disorders in French general practice using the patient health questionnaire: comparison with GP case-recognition and psychotropic medication prescription].
Norton J; de Roquefeuil G; David M; Boulenger JP; Ritchie K; Mann A
Encephale; 2009 Dec; 35(6):560-9. PubMed ID: 20004287
[TBL] [Abstract][Full Text] [Related]
5. Paroxetine: an update of its use in psychiatric disorders in adults.
Wagstaff AJ; Cheer SM; Matheson AJ; Ormrod D; Goa KL
Drugs; 2002; 62(4):655-703. PubMed ID: 11893234
[TBL] [Abstract][Full Text] [Related]
6. The structure of the genetic and environmental risk factors for six major psychiatric disorders in women. Phobia, generalized anxiety disorder, panic disorder, bulimia, major depression, and alcoholism.
Kendler KS; Walters EE; Neale MC; Kessler RC; Heath AC; Eaves LJ
Arch Gen Psychiatry; 1995 May; 52(5):374-83. PubMed ID: 7726718
[TBL] [Abstract][Full Text] [Related]
7. A Web-based screening instrument for depression and anxiety disorders in primary care.
Farvolden P; McBride C; Bagby RM; Ravitz P
J Med Internet Res; 2003; 5(3):e23. PubMed ID: 14517114
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic applications and mechanisms of action of monoamine oxidase inhibitor and heterocyclic antidepressant drugs.
Goodman WK; Charney DS
J Clin Psychiatry; 1985 Oct; 46(10 Pt 2):6-24. PubMed ID: 3900056
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of drug treatment in obsessive-compulsive disorder. A meta-analytic review.
Piccinelli M; Pini S; Bellantuono C; Wilkinson G
Br J Psychiatry; 1995 Apr; 166(4):424-43. PubMed ID: 7795913
[TBL] [Abstract][Full Text] [Related]
10. [Depressive symptoms during anorexia nervosa: State of the art and consequences for an appropriate use of antidepressants].
Leblé N; Radon L; Rabot M; Godart N
Encephale; 2017 Feb; 43(1):62-68. PubMed ID: 27452149
[TBL] [Abstract][Full Text] [Related]
11. Combined Oral Contraceptive Pill Initiation in a Patient With Major Depressive Disorder, Premenstrual Dysphoric Disorder, Social Anxiety, Panic Disorder, and Histrionic Personality Disorder.
Roi C; Conrad EJ
Ochsner J; 2017; 17(2):181-183. PubMed ID: 28638292
[TBL] [Abstract][Full Text] [Related]
12. Antidepressant drugs: additional clinical uses.
Orsulak PJ; Waller D
J Fam Pract; 1989 Feb; 28(2):209-16. PubMed ID: 2644393
[TBL] [Abstract][Full Text] [Related]
13. Should we expand the toolbox of psychiatric treatment methods to include Repetitive Transcranial Magnetic Stimulation (rTMS)? A meta-analysis of the efficacy of rTMS in psychiatric disorders.
Slotema CW; Blom JD; Hoek HW; Sommer IE
J Clin Psychiatry; 2010 Jul; 71(7):873-84. PubMed ID: 20361902
[TBL] [Abstract][Full Text] [Related]
14. Initial severity and antidepressant efficacy for anxiety disorders, obsessive-compulsive disorder, and posttraumatic stress disorder: An individual patient data meta-analysis.
de Vries YA; Roest AM; Burgerhof JGM; de Jonge P
Depress Anxiety; 2018 Jun; 35(6):515-522. PubMed ID: 29659102
[TBL] [Abstract][Full Text] [Related]
15. Using antipsychotic agents in older patients.
Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
[TBL] [Abstract][Full Text] [Related]
16. Clomipramine. An overview of its pharmacological properties and a review of its therapeutic use in obsessive compulsive disorder and panic disorder.
McTavish D; Benfield P
Drugs; 1990 Jan; 39(1):136-53. PubMed ID: 2178909
[TBL] [Abstract][Full Text] [Related]
17. A systematic review of off-label uses of memantine for psychiatric disorders.
Zdanys K; Tampi RR
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug; 32(6):1362-74. PubMed ID: 18262702
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
